Lista de obras -

2013 update of the American Society of Clinical Oncology/College of American Pathologists guideline for human epidermal growth factor receptor 2 testing: impact on immunohistochemistry-negative breast cancers.

artículo científico publicado en 2014

A nanobody targeting the F-actin capping protein CapG restrains breast cancer metastasis

artículo científico publicado en 2013

A plea for appraisal and appreciation of immunohistochemistry in the assessment of prognostic and predictive markers in invasive breast cancer

artículo científico publicado en 2017

Accurate detection and quantification of epigenetic and genetic second hits in BRCA1 and BRCA2-associated hereditary breast and ovarian cancer reveals multiple co-acting second hits.

artículo científico publicado en 2018

An immunohistochemical analysis of Rab27B distribution in fetal and adult tissue

artículo científico publicado en 2012

Analysis of microsatellite instability in gastric mucosa-associated lymphoid tissue lymphoma

artículo científico publicado en 2012

Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling

artículo científico publicado en 2012

CCN5, a Novel Transcriptional Repressor of the Transforming Growth Factor β Signaling Pathway ⬇️

artículo científico publicado el 24 de enero de 2011

Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak/STAT3 signaling.

artículo científico publicado en 2014

Collagen Alignment and Recurrence of DCIS-Letter

artículo científico publicado en 2018

Comparative analysis of cervical cytology and human papillomavirus genotyping by three different methods in a routine diagnostic setting

artículo científico publicado en 2015

Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression.

artículo científico publicado en 2017

Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs

artículo científico publicado en 2009

Completion surgery after intensity-modulated arc therapy in the treatment of locally advanced cervical cancer: feasibility, surgical outcome, and oncologic results

artículo científico publicado en 2013

Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial inter-observer concordance

artículo científico publicado en 2018

Differential regulation of extracellular matrix protein expression in carcinoma-associated fibroblasts by TGF-β1 regulates cancer cell spreading but not adhesion.

artículo científico publicado en 2014

Distinguishing score 0 from score 1+ in HER2 immunohistochemistry-negative breast cancer: clinical and pathobiological relevance

artículo científico publicado en 2013

Fine Tuning of the Van Nuys Prognostic Index (VNPI) 2003 by Integrating the Genomic Grade Index (GGI): New Tools for Ductal Carcinoma In Situ (DCIS) ⬇️

artículo científico publicado el 6 de junio de 2011

HER2 protein overexpression in non-amplified ductal carcinoma in situ: quality issue or transcription mechanisms gone awry?

scientific article published on 15 January 2019

Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype.

artículo científico publicado en 2014

Identification of a GαGβγ, AKT and PKCα signalome associated with invasive growth in two genetic models of human breast cancer cell epithelial-to-mesenchymal transition

artículo científico publicado en 2012

Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study

scientific article published on 18 September 2019

Lymphoplasmacytic lymphoma exposed by haemoptysis and acquired von Willebrand syndrome

artículo científico publicado en 2014

Ovarian small cell carcinoma and cytokeratin perinuclear dotlike staining

artículo científico publicado en 2008

Postoperative Intensity-Modulated Arc Therapy for Cervical and Endometrial Cancer: A Prospective Report on Toxicity ⬇️

artículo científico publicado el 28 de febrero de 2012

Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study

artículo científico publicado en 2009

Radiation-induced myosin IIA expression stimulates collagen type I matrix reorganization.

artículo científico publicado en 2013

Relationship between pathological features, HER2 protein expression and HER2 and CEP17 copy number in breast cancer: biological and methodological considerations

artículo científico publicado en 2010

Stromal architecture and periductal decorin are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ of the breast.

artículo científico publicado en 2013

Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast

scientific article published on 12 November 2018

The Baader-Meinhof phenomenon in ductal carcinoma in situ of the breast.

artículo científico publicado en 2016

The extracellular matrix regulates cancer progression and therapy response: implications for prognosis and treatment

artículo científico publicado en 2009

Vacuolar H+ ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer

artículo científico publicado en 2013

Value of magnetic resonance and ¹⁸FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy: a prospective pathology-matched study

artículo científico publicado en 2012

Lista de obras de

2013 update of the American Society of Clinical Oncology/College of American Pathologists guideline for human epidermal growth factor receptor 2 testing: impact on immunohistochemistry-negative breast cancers.

A nanobody targeting the F-actin capping protein CapG restrains breast cancer metastasis

A plea for appraisal and appreciation of immunohistochemistry in the assessment of prognostic and predictive markers in invasive breast cancer

Accurate detection and quantification of epigenetic and genetic second hits in BRCA1 and BRCA2-associated hereditary breast and ovarian cancer reveals multiple co-acting second hits.

An immunohistochemical analysis of Rab27B distribution in fetal and adult tissue

Analysis of microsatellite instability in gastric mucosa-associated lymphoid tissue lymphoma

Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling

CCN5, a Novel Transcriptional Repressor of the Transforming Growth Factor β Signaling Pathway ⬇️

Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak/STAT3 signaling.

Collagen Alignment and Recurrence of DCIS-Letter

Comparative analysis of cervical cytology and human papillomavirus genotyping by three different methods in a routine diagnostic setting

Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression.

Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs

Completion surgery after intensity-modulated arc therapy in the treatment of locally advanced cervical cancer: feasibility, surgical outcome, and oncologic results

Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial inter-observer concordance

Differential regulation of extracellular matrix protein expression in carcinoma-associated fibroblasts by TGF-β1 regulates cancer cell spreading but not adhesion.

Distinguishing score 0 from score 1+ in HER2 immunohistochemistry-negative breast cancer: clinical and pathobiological relevance

Fine Tuning of the Van Nuys Prognostic Index (VNPI) 2003 by Integrating the Genomic Grade Index (GGI): New Tools for Ductal Carcinoma In Situ (DCIS) ⬇️

HER2 protein overexpression in non-amplified ductal carcinoma in situ: quality issue or transcription mechanisms gone awry?

Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype.

Identification of a GαGβγ, AKT and PKCα signalome associated with invasive growth in two genetic models of human breast cancer cell epithelial-to-mesenchymal transition

Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study

Lymphoplasmacytic lymphoma exposed by haemoptysis and acquired von Willebrand syndrome

Ovarian small cell carcinoma and cytokeratin perinuclear dotlike staining

Postoperative Intensity-Modulated Arc Therapy for Cervical and Endometrial Cancer: A Prospective Report on Toxicity ⬇️

Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study

Radiation-induced myosin IIA expression stimulates collagen type I matrix reorganization.

Relationship between pathological features, HER2 protein expression and HER2 and CEP17 copy number in breast cancer: biological and methodological considerations

Stromal architecture and periductal decorin are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ of the breast.

Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast

The Baader-Meinhof phenomenon in ductal carcinoma in situ of the breast.

The extracellular matrix regulates cancer progression and therapy response: implications for prognosis and treatment

Vacuolar H+ ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer

Value of magnetic resonance and ¹⁸FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy: a prospective pathology-matched study